Manchester Capital Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.4K Sell
56
-3
-5% -$734 ﹤0.01% 761
2025
Q4
$15K Buy
59
+3
+5% +$753 ﹤0.01% 715
2025
Q3
$13.9K Sell
56
-7
-11% -$1.68K ﹤0.01% 813
2025
Q2
$15.1K Sell
63
-180
-74% -$41.9K ﹤0.01% 773
2025
Q1
$55.1K Buy
243
+31
+15% +$6.82K 0.01% 532
2024
Q4
$43.6K Buy
212
+137
+183% +$30.1K 0.01% 562
2024
Q3
$18.2K Buy
75
+1
+1% +$234 ﹤0.01% 702
2024
Q2
$16.2K Buy
74
+51
+222% +$11.1K ﹤0.01% 688
2024
Q1
$5.17K Buy
23
+7
+44% +$1.58K ﹤0.01% 727
2023
Q4
$3.52K Buy
16
+6
+60% +$1.27K ﹤0.01% 747
2023
Q3
$2.19K Buy
10
+6
+150% +$1.36K ﹤0.01% 759
2023
Q2
$900 Sell
4
-2,764
-100% -$553K ﹤0.01% 820
2023
Q1
$529K Buy
+2,768
New +$535K 0.07% 173
2022
Q2
Sell
-7
Closed -$2K 1140
2022
Q1
$2K Hold
7
﹤0.01% 865
2021
Q4
$2K Buy
+7
New +$1.6K ﹤0.01% 875
2015
Q1
Sell
-1,325
Closed -$86K 836
2014
Q4
$86K Buy
+1,325
New +$81.8K 0.01% 592

Other funds holding STE

Manchester Capital Management's STE Position: Q1 2026 in Review

Manchester Capital Management reduced its Steris (STE) stake by 5.1% in Q1 2026, selling an estimated $734 and leaving 56 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #761.

Manchester Capital Management first reported a position in STE in Q4 2014 and has held it in 16 quarters since. The position peaked at $529K in Q1 2023. 840 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Manchester Capital Management held 56 shares of Steris worth $12.4K as of Q1 2026.
  • Manchester Capital Management sold 3 Steris shares in Q1 2026, an estimated $734.
  • Steris made up ﹤0.01% of Manchester Capital Management's portfolio in Q1 2026, its #761 holding.
  • Manchester Capital Management first reported a position in Steris in Q4 2014 and has held it in 16 quarters since.
  • Manchester Capital Management's Steris position peaked at $529K in Q1 2023.
  • 840 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.